References
- Abadie, D., Essilini, A., Fulda, V., Gouraud, A., Yéléhé-Okouma, M., Micallef, J., Montastruc, F., & Montastruc, J. L. (2017). Drug-induced panic attacks: Analysis of cases registered in the French pharmacovigilance database. Journal of Psychiatric Research, 90, 60–66. https://doi.org/https://doi.org/10.1016/j.jpsychires.2017.02.008
- Akiyama, Y., Nishimura, M., Kobayashi, S., Yoshioka, A., Yamamoto, M., Miyamoto, K., & Kawakami, Y. (1993). Effects of naloxone on the sensation of dyspnea during acute respiratory stress in normal adults. Journal of Applied Physiology, 74(2), 590–595. https://doi.org/https://doi.org/10.1152/jappl.1993.74.2.590
- Alanis-Hirsch, K., Croff, R., Ford, J. H., Johnson, K., Chalk, M., Schmidt, L., & McCarty, D. (2016). Extended-release naltrexone: A qualitative analysis of barriers to routine use. Journal of Substance Abuse Treatment, 62, 68–73. https://doi.org/https://doi.org/10.1016/j.jsat.2015.10.003
- Amato, L., Minozzi, S., Davoli, M., & Vecchi, S. (2011). Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence. Cochrane Database of Systematic Reviews, 10, CD004147. https://doi.org/https://doi.org/10.1002/14651858.CD004147.pub4
- American Psychiatric Association. (2009). Practice guideline for the treatment of patients with panic disorder. American Psychiatric Association.
- American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (DSM-5®). American Psychiatric Pub.
- Andraka-Christou, B., & Capone, M. J. (2018). A qualitative study comparing physician-reported barriers to treating addiction using buprenorphine and extended-release naltrexone in U.S. office-based practices. The International Journal on Drug Policy, 54, 9–17. https://doi.org/https://doi.org/10.1016/j.drugpo.2017.11.021
- Ashton, H. (1994). Guidelines for the rational use of benzodiazepines. When and what to use. Drugs, 48(1), 25–40. https://doi.org/https://doi.org/10.2165/00003495-199448010-00004
- Back, S. E., Dansky, B. S., Carroll, K. M., Foa, E. B., & Brady, K. T. (2001). Exposure therapy in the treatment of PTSD among cocaine-dependent individuals: Description of procedures. Journal of Substance Abuse Treatment, 21(1), 35–45. https://doi.org/https://doi.org/10.1016/S0740-5472(01)00181-7
- Back, S. E., Killeen, T. K., Teer, A. P., Hartwell, E. E., Federline, A., Beylotte, F., & Cox, E. (2014). Substance use disorders and PTSD: An exploratory study of treatment preferences among military veterans. Addictive Behaviors, 39(2), 369–373. https://doi.org/https://doi.org/10.1016/j.addbeh.2013.09.017
- Back, S. E., Killeen, T., Badour, C. L., Flanagan, J. C., Allan, N. P., Ana, E. S., Lozano, B., Korte, K. J., Foa, E. B., & Brady, K. T. (2019). Concurrent treatment of substance use disorders and PTSD using prolonged exposure: A randomized clinical trial in military veterans. Addictive Behaviors, 90, 369–377. https://doi.org/https://doi.org/10.1016/j.addbeh.2018.11.032
- Bakken, K., Landheim, A. S., & Vaglum, P. (2007). Axis I and II disorders as long-term predictors of mental distress: A six-year prospective follow-up of substance-dependent patients. BMC Psychiatry, 7, 29. https://doi.org/https://doi.org/10.1186/1471-244X-7-29
- Baldwin, D. S., Anderson, I. M., Nutt, D. J., Allgulander, C., Bandelow, B., den Boer, J. A., Christmas, D. M., Davies, S., Fineberg, N., Lidbetter, N., Malizia, A., McCrone, P., Nabarro, D., O'Neill, C., Scott, J., van der Wee, N., & Wittchen, H.-U. (2014). Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: A revision of the 2005 guidelines from the British Association for Psychopharmacology. Journal of Psychopharmacology, 28(5), 403–439. https://doi.org/https://doi.org/10.1177/0269881114525674
- Barry, D. T., Fazzino, T., Necrason, E., Ginn, J., Fiellin, L. E., Fiellin, D. A., & Moore, B. A. (2016). The availability of ancillary counseling in the practices of physicians prescribing buprenorphine. Journal of Addiction Medicine, 10(5), 352–356. https://doi.org/https://doi.org/10.1097/ADM.0000000000000247
- Bart, G. (2012). Maintenance medication for opiate addiction: The foundation of recovery. Journal of Addictive Diseases, 31(3), 207–225. https://doi.org/https://doi.org/10.1080/10550887.2012.694598
- Batelaan, N., Smit, F., Graaf, R. d., Balkom, A. v., Vollebergh, W., & Beekman, A. (2007). Economic costs of full-blown and subthreshold panic disorder. Journal of Affective Disorders, 104(1–3), 127–136. https://doi.org/https://doi.org/10.1016/j.jad.2007.03.013
- Battaglia, M., Pesenti-Gritti, P., Medland, S. E., Ogliari, A., Tambs, K., & Spatola, C. A. M. (2009). A genetically informed study of the association between childhood separation anxiety, sensitivity to CO(2), panic disorder, and the effect of childhood parental loss. Archives of General Psychiatry, 66(1), 64–71. https://doi.org/https://doi.org/10.1001/archgenpsychiatry.2008.513
- Becker, W. C., Sullivan, L. E., Tetrault, J. M., Desai, R. A., & Fiellin, D. A. (2008). Non-medical use, abuse and dependence on prescription opioids among U.S. adults: Psychiatric, medical and substance use correlates. Drug and Alcohol Dependence, 94(1–3), 38–47. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2007.09.018
- Bizzarri, J. V., Rucci, P., Sbrana, A., Gonnelli, C., Massei, G. J., Ravani, L., Girelli, M., Dell'osso, L., & Cassano, G. B. (2007). Reasons for substance use and vulnerability factors in patients with substance use disorder and anxiety or mood disorders. Addictive Behaviors, 32(2), 384–391. https://doi.org/https://doi.org/10.1016/j.addbeh.2006.04.005
- Boettcher, H., & Barlow, D. H. (2019). The unique and conditional effects of interoceptive exposure in the treatment of anxiety: A functional analysis. Behaviour Research and Therapy, 117, 65–78. https://doi.org/https://doi.org/10.1016/j.brat.2018.12.002
- Bolton, J., Cox, B., Clara, I., & Sareen, J. (2006). Use of alcohol and drugs to self-medicate anxiety disorders in a nationally representative sample. The Journal of Nervous and Mental Disease, 194(11), 818–825. https://doi.org/https://doi.org/10.1097/01.nmd.0000244481.63148.98
- Brady, K. T., Dansky, B. S., Back, S. E., Foa, E. B., & Carroll, K. M. (2001). Exposure therapy in the treatment of PTSD among cocaine-dependent individuals: Preliminary findings. Journal of Substance Abuse Treatment, 21(1), 47–54. https://doi.org/https://doi.org/10.1016/s0740-5472(01)00182-9
- Brady, K. T., Haynes, L. F., Hartwell, K. J., & Killeen, T. K. (2013). Substance use disorders and anxiety: A treatment challenge for social workers. Social Work in Public Health, 28(3–4), 407–423. https://doi.org/https://doi.org/10.1080/19371918.2013.774675
- Center for Substance Abuse Treatment. (2004). Clinical guidelines for the use of buprenorphine in the treatment of opioid addiction. Substance Abuse and Mental Health Services Administration.
- Cohen, M. R., Cohen, R. M., Pickar, D., Weingartner, H., & Murphy, D. L. (1983). High-dose naloxone infusions in normals. Dose-dependent behavioral, hormonal, and physiological responses. Archives of General Psychiatry, 40(6), 613–619. https://doi.org/https://doi.org/10.1001/archpsyc.1983.04390010023003
- Connery, H. S. (2015). Medication-assisted treatment of opioid use disorder: Review of the evidence and future directions. Harvard Review of Psychiatry, 23(2), 63–75. https://doi.org/https://doi.org/10.1097/HRP.0000000000000075
- Conway, K. P., Compton, W., Stinson, F. S., & Grant, B. F. (2006). Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. The Journal of Clinical Psychiatry, 67(02), 247–257. https://doi.org/https://doi.org/10.4088/jcp.v67n0211
- Darke, S., & Ross, J. (1997). Polydrug dependence and psychiatric comorbidity among heroin injectors. Drug and Alcohol Dependence, 48(2), 135–141. https://doi.org/https://doi.org/10.1016/S0376-8716(97)00117-8
- Deacon, B., Kemp, J. J., Dixon, L. J., Sy, J. T., Farrell, N. R., & Zhang, A. R. (2013). Maximizing the efficacy of interoceptive exposure by optimizing inhibitory learning: A randomized controlled trial. Behaviour Research and Therapy, 51(9), 588–596. https://doi.org/https://doi.org/10.1016/j.brat.2013.06.006
- Deakin, J. F. W., & Graeff, F. G. (1991). 5-HT and mechanisms of defence. Journal of Psychopharmacology, 5(4), 305–315. https://doi.org/https://doi.org/10.1177/026988119100500414
- Devane, C. L., Chiao, E., Franklin, M., & Kruep, E. J. (2005). Anxiety disorders in the 21st century: Status, challenges, opportunities, and comorbidity with depression. The American Journal of Managed Care, 11(12 Suppl), S344–S353.
- Drake, R. E. (2007). Dual diagnosis. Psychiatry, 6(9), 381–384. https://doi.org/https://doi.org/10.1016/j.mppsy.2007.07.001
- Dugosh, K., Abraham, A., Seymour, B., McLoyd, K., Chalk, M., & Festinger, D. (2016). A systematic review on the use of psychosocial interventions in conjunction with medications for the treatment of opioid addiction. Journal of Addiction Medicine, 10(2), 93–101. https://doi.org/https://doi.org/10.1097/ADM.0000000000000193
- Eidson, L. N., Inoue, K., Young, L. J., Tansey, M. G., & Murphy, A. Z. (2017). Toll-like receptor 4 mediates morphine-induced neuroinflammation and tolerance via soluble tumor necrosis factor signaling. Neuropsychopharmacology, 42(3), 661–670. https://doi.org/https://doi.org/10.1038/npp.2016.131
- Esquivel, G., Fernández-Torre, O., Schruers, K., Wijnhoven, L., & Griez, E. (2009). The effects of opioid receptor blockade on experimental panic provocation with CO2. Journal of Psychopharmacology, 23(8), 975–978. https://doi.org/https://doi.org/10.1177/0269881108093844
- Flanagan, J. C., Korte, K. J., Killeen, T. K., & Back, S. E. (2016). Concurrent treatment of substance use and PTSD. Current Psychiatry Reports, 18(8), 70. https://doi.org/https://doi.org/10.1007/s11920-016-0709-y.
- Florence, C., Luo, F., Xu, L., & Zhou, C. (2016). The economic burden of prescription opioid overdose, abuse, and dependence in the United States, 2013. Medical Care, 54(10), 901–906. https://doi.org/https://doi.org/10.1097/MLR.0000000000000625
- Gajecki, M., Berman, A. H., Sinadinovic, K., Andersson, C., Ljótsson, B., Hedman, E., Rück, C., & Lindefors, N. (2014). Effects of baseline problematic alcohol and drug use on internet-based cognitive behavioral therapy outcomes for depression, panic disorder and social anxiety disorder. PLOS One, 9(8), e104615. https://doi.org/https://doi.org/10.1371/journal.pone.0104615
- George, D. T., Ameli, R., & Koob, G. F. (2019). Periaqueductal gray sheds light on dark areas of psychopathology. Trends in Neuroscience, 42(5), 349–360. https://doi.org/https://doi.org/10.1016/j.tins.2019.03.004
- Goodwin, R. D., Stayner, D. A., Chinman, M. J., Wu, P., Tebes, J. K., & Davidson, L. (2002). The relationship between anxiety and substance use disorders among individuals with severe affective disorders. Comprehensive Psychiatry, 43(4), 245–252. https://doi.org/https://doi.org/10.1053/comp.2002.33500
- Graeff, F. G. (2017). Translational approach to the pathophysiology of panic disorder: Focus on serotonin and endogenous opioids. Neuroscience and Biobehavioral Reviews, 76(Pt A), 48–55. https://doi.org/https://doi.org/10.1016/j.neubiorev.2016.10.013
- Grant, B. F., Saha, T. D., Ruan, W. J., Goldstein, R. B., Chou, S. P., Jung, J., Zhang, H., Smith, S. M., Pickering, R. P., Huang, B., & Hasin, D. S. (2016). Epidemiology of DSM-5 drug use disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions-III. JAMA Psychiatry, 73(1), 39–47. https://doi.org/https://doi.org/10.1001/jamapsychiatry.2015.2132
- Greenberg, P. E., Sisitsky, T., Kessler, R. C., Finkelstein, S. N., Berndt, E. R., Davidson, J. R., Ballenger, J. C., & Fyer, A. J. (1999). The economic burden of anxiety disorders in the 1990s. The Journal of Clinical Psychiatry, 60(7), 427–435. https://doi.org/https://doi.org/10.4088/JCP.v60n0702
- Hasin, D. S., & Grant, B. F. (2015). The National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) waves 1 and 2: Review and summary of findings. Social Psychiatry and Psychiatric Epidemiology, 50(11), 1609–1640. https://doi.org/https://doi.org/10.1007/s00127-015-1088-0
- Hassan, A. N., & Nunes, E. (2018). Medication treatments for opioid use disorder: What is the impact on mood and mood disorders? Current Addiction Reports, 5(3), 303–311. https://doi.org/https://doi.org/10.1007/s40429-018-0215-x
- Hettema, J. M., Prescott, C. A., Myers, J. M., Neale, M. C., & Kendler, K. S. (2005). The structure of genetic and environmental risk factors for anxiety disorders in men and women. Archives of General Psychiatry, 62(2), 182–189. https://doi.org/https://doi.org/10.1001/archpsyc.62.2.182
- Hien, D. A., Cohen, L. R., Miele, G. M., Litt, L. C., & Capstick, C. (2004). Promising treatments for women with comorbid PTSD and substance use disorders. The American Journal of Psychiatry, 161(8), 1426–1432. https://doi.org/https://doi.org/10.1176/appi.ajp.161.8.1426
- Hien, D. A., Wells, E. A., Jiang, H., Suarez-Morales, L., Campbell, A. N. C., Cohen, L. R., Miele, G. M., Killeen, T., Brigham, G. S., Zhang, Y., Hansen, C., Hodgkins, C., Hatch-Maillette, M., Brown, C., Kulaga, A., Kristman-Valente, A., Chu, M., Sage, R., Robinson, J. A., Liu, D., & Nunes, E. V. (2009). Multisite randomized trial of behavioral interventions for women with co-occurring PTSD and substance use disorders. Journal of Consulting and Clinical Psychology, 77(4), 607–619. https://doi.org/https://doi.org/10.1037/a0016227
- Iida, T., Yi, H., Liu, S., Ikegami, D., Zheng, W., Liu, Q., Takahashi, K., Kashiwagi, Y., Goins, W. F., Glorioso, J. C., & Hao, S. (2017). MnSOD mediated by HSV vectors in the periaqueductal gray suppresses morphine withdrawal in rats. Gene Therapy, 24(5), 314–324. https://doi.org/https://doi.org/10.1038/gt.2017.22
- Jann, M., Kennedy, W. K., & Lopez, G. (2014). Benzodiazepines: A major component in unintentional prescription drug overdoses with opioid analgesics. Journal of Pharmacy Practice, 27(1), 5–16. https://doi.org/https://doi.org/10.1177/0897190013515001
- de Jonge, P., Roest, A. M., Lim, C. C. W., Florescu, S. E., Bromet, E. J., Stein, D. J., Harris, M., Nakov, V., Caldas-de-Almeida, J. M., Levinson, D., Al-Hamzawi, A. O., Haro, J. M., Viana, M. C., Borges, G., O'Neill, S., de Girolamo, G., Demyttenaere, K., Gureje, O., Iwata, N., … Scott, K. M. (2016). Cross-national epidemiology of panic disorder and panic attacks in the world mental health surveys. Depression and Anxiety, 33(12), 1155–1177. https://doi.org/https://doi.org/10.1002/da.22572
- Kendler, K. S., Neale, M. C., Kessler, R. C., Heath, A. C., & Eaves, L. J. (1992). Childhood parental loss and adult psychopathology in women. A twin study perspective. Archives of General Psychiatry, 49(2), 109–116. https://doi.org/https://doi.org/10.1001/archpsyc.1992.01820020029004
- Kendler, K. S., Prescott, C. A., Myers, J., & Neale, M. C. (2003). The structure of genetic and environmental risk factors for common psychiatric and substance use disorders in men and women. Archives of General Psychiatry, 60(9), 929–937. https://doi.org/https://doi.org/10.1001/archpsyc.60.9.929
- Klein, E., Colin, V., Stolk, J., & Lenox, R. H. (1994). Alprazolam withdrawal in patients with panic disorder and generalized anxiety disorder: Vulnerability and effect of carbamazepine. The American Journal of Psychiatry, 151(12), 1760–1766. https://doi-org.proxy-hs.researchport.umd.edu/https://doi.org/10.1176/ajp.151.12.1760
- Kok, T., de Haan, H. A., van der Meer, M., Najavits, L. M., & DeJong, C. A. (2013). Efficacy of “seeking safety” in a Dutch population of traumatized substance-use disorder outpatients: Study protocol of a randomized controlled trial. BMC Psychiatry, 13(1), 162. https://doi.org/https://doi.org/10.1186/1471-244X-13-162
- Krueger, R. F., McGue, M., & Iacono, W. G. (2001). The higher-order structure of common DSM mental disorders: Internalization, externalization, and their connections to personality. Personality and Individual Differences, 30(7), 1245–1259. https://doi.org/https://doi.org/10.1016/S0191-8869(00)00106-9
- Kuch, K., Cox, B. J., Woszczyna, C. B., Swinson, R. P., & Shulman, I. (1991). Chronic pain in panic disorder. Journal of Behavior Therapy and Experimental Psychiatry, 22(4), 255–259. https://doi.org/https://doi.org/10.1016/0005-7916(91)90041-3
- Lancaster, C. L., Gros, D. F., Mullarkey, M. C., Badour, C. L., Killeen, T. K., Brady, K. T., & Back, S. E. (2020). Does trauma-focused exposure therapy exacerbate symptoms among patients with comorbid PTSD and substance use disorders? Behavioural and Cognitive Psychotherapy, 48(1), 38–53. https://doi.org/https://doi.org/10.1017/S1352465819000304
- Latif, Z-E-H., Šaltyte Benth, J., Solli, K. K., Opheim, A., Kunoe, N., Krajci, P., Sharma-Haase, K., & Tanum, L. (2019). Anxiety, depression, and insomnia among adults with opioid dependence treated with extended-release naltrexone vs buprenorphine-naloxone: A randomized clinical trial and follow-up study. JAMA Psychiatry, 76(2), 127–134. https://doi.org/https://doi.org/10.1001/jamapsychiatry.2018.3537
- Lee, J. D., Nunes, E. V., Novo, P., Bachrach, K., Bailey, G. L., Bhatt, S., Farkas, S., Fishman, M., Gauthier, P., Hodgkins, C. C., King, J., Lindblad, R., Liu, D., Matthews, A. G., May, J., Peavy, K. M., Ross, S., Salazar, D., Schkolnik, P., … Rotrosen, J. (2018). Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): A multicentre, open-label, randomised controlled trial. The Lancet, 391(10118), 309–318. https://doi.org/https://doi.org/10.1016/S0140-6736(17)32812-X
- Lejuez, C. W., Paulson, A., Daughters, S. B., Bornovalova, M. A., & Zvolensky, M. J. (2006). The association between heroin use and anxiety sensitivity among inner-city individuals in residential drug use treatment. Behaviour Research and Therapy, 44(5), 667–677. https://doi.org/https://doi.org/10.1016/j.brat.2005.04.006
- Levis, S. C., Bentzley, B. S., Molet, J., Bolton, J. L., Perrone, C. R., Baram, T. Z., & Mahler, S. V. (2019). On the early life origins of vulnerability to opioid addiction. Molecular Psychiatry, 1–8. https://doi.org/https://doi.org/10.1038/s41380-019-0628-5
- Lewinsohn, P. M., Holm-Denoma, J. M., Small, J. W., Seeley, J. R., & Joiner, T. E. (2008). Separation anxiety disorder in childhood as a risk factor for future mental illness. Journal of the American Academy of Child and Adolescent Psychiatry, 47(5), 548–555. https://doi.org/https://doi.org/10.1097/CHI.0b013e31816765e7
- Lovallo, W. R., Acheson, A., Vincent, A. S., Sorocco, K. H., & Cohoon, A. J. (2018). Early life adversity diminishes the cortisol response to opioid blockade in women: Studies from the family health patterns project. PLoS One, 13(10), e0205723. https://doi.org/https://doi.org/10.1371/journal.pone.0205723
- Lynch, P., & Galbraith, K. M. (2003). Panic in the emergency room. Canadian Journal of Psychiatry, 48(6), 361–366. https://doi.org/https://doi.org/10.1177/070674370304800601
- Ma, J., Bao, Y.-P., Wang, R.-J., Su, M.-F., Liu, M.-X., Li, J.-Q., Degenhardt, L., Farrell, M., Blow, F. C., Ilgen, M., Shi, J., & Lu, L. (2019). Effects of medication-assisted treatment on mortality among opioids users: A systematic review and meta-analysis. Molecular Psychiatry, 24(12), 1868–1883. https://doi.org/https://doi.org/10.1038/s41380-018-0094-5
- Mangrum, L. F., Spence, R. T., & Lopez, M. (2006). Integrated versus parallel treatment of co-occurring psychiatric and substance use disorders. Journal of Substance Abuse Treatment, 30(1), 79–84. https://doi.org/https://doi.org/10.1016/j.jsat.2005.10.004
- Maraschin, J. C., Rangel, M. P., Bonfim, A. J., Kitayama, M., Graeff, F. G., Zangrossi, H., & Audi, E. A. (2016). Opiorphin causes a panicolytic-like effect in rat panic models mediated by μ-opioid receptors in the dorsal periaqueductal gray. Neuropharmacology, 101, 264–270. https://doi.org/https://doi.org/10.1016/j.neuropharm.2015.09.008
- Maraschin, J. C., Sestile, C. C., Yabiku, C. T., Roncon, C. M., de Souza Fiaes, G. C., Graeff, F. G., Audi, E. A., & Zangrossi, H. (2020). Effects of the adjunctive treatment of antidepressants with opiorphin on a panic-like defensive response in rats. Behavioural Brain Research, 378, 112263https://doi.org/https://doi.org/10.1016/j.bbr.2019.112263
- Maremmani, I., Pani, P. P., Pacini, M., Bizzarri, J. V., Trogu, E., Maremmani, A. G., Gerra, G., Perugi, G., & Dell'Osso, L. (2010). Subtyping patients with heroin addiction at treatment entry: Factor derived from the Self-Report Symptom Inventory (SCL-90). Annals of General Psychiatry, 9, 15. https://doi.org/https://doi.org/10.1186/1744-859X-9-15
- Marmorstein, N. R. (2012). Anxiety disorders and substance use disorders: Different associations by anxiety disorder. Journal of Anxiety Disorder, 26(1), 88–94. https://doi.org/https://doi.org/10.1016/j.janxdis.2011.09.005
- Martins, S. S., Fenton, M. C., Keyes, K. M., Blanco, C., Zhu, H., & Storr, C. L. (2012). Mood/Anxiety disorders and their association with non-medical prescription opioid use and prescription opioid use disorder: Longitudinal evidence from the National Epidemiologic Study on Alcohol and Related Conditions. Psychological Medicine, 42(6), 1261–1272. https://doi.org/https://doi.org/10.1017/S0033291711002145
- Martins, S. S., Keyes, K. M., Storr, C. L., Zhu, H., & Chilcoat, H. D. (2009). Pathways between nonmedical opioid use/dependence and psychiatric disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug and Alcohol Dependence, 103(1–2), 16–24. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2009.01.019
- McCrady, B., Witkiewitz, K., Venner, K., & Fokas, K. (2020). Education and training in substance use disorders and addictions: The University of New Mexico Integrated Training Model. Training and Education in Professional Psychology, 14(1), 60–69. https://doi.org/https://doi.org/10.1037/tep0000287
- McHugh, R. K. (2015). Treatment of co-occurring anxiety disorders and substance use disorders. Harvard Review of Psychiatry, 23(2), 99–111. https://doi.org/https://doi.org/10.1097/HRP.0000000000000058
- McHugh, R. K., Taghian, N. R., & Nguyen, M. D. (2021). Anxiety and opioid use disorder: Potential targets for treatment and prevention. Current Addiction Reports, 8, 136–143. https://doi-org.proxy-hs.researchport.umd.edu/https://doi.org/10.1007/s40429-020-00350-8
- McHugh, R. K., Votaw, V. R., Barlow, D. H., Fitzmaurice, G. M., Greenfield, S. F., & Weiss, R. D. (2017). Development of an integrated cognitive behavioral therapy for anxiety and opioid use disorder: Study protocol and methods. Contemporary Clinical Trials, 60, 105–112. https://doi.org/https://doi.org/10.1016/j.cct.2017.07.006
- McKee, S. A. (2017). Concurrent substance use disorders and mental illness: Bridging the gap between research and treatment. Psychologie Canadienne [Canadian Psychology], 58(1), 50–57. https://doi.org/https://doi.org/10.1037/cap0000093
- McWilliams, L. A., Cox, B. J., & Enns, M. W. (2003). Mood and anxiety disorders associated with chronic pain: An examination in a nationally representative sample. Pain, 106(1), 127–133. https://doi.org/https://doi.org/10.1016/S0304-3959(03)00301-4
- Mills, K. L., Teesson, M., Back, S. E., Brady, K. T., Baker, A. L., Hopwood, S., Sannibale, C., Barrett, E. L., Merz, S., Rosenfeld, J., & Ewer, P. L. (2012). Integrated exposure-based therapy for co-occurring posttraumatic stress disorder and substance dependence: A randomized controlled trial. JAMA, 308(7), 690–699. https://doi.org/https://doi.org/10.1001/jama.2012.9071
- Mobbs, D., Petrovic, P., Marchant, J. L., Hassabis, D., Weiskopf, N., Seymour, B., Dolan, R. J., & Frith, C. D. (2007). When fear is near: Threat imminence elicits prefrontal-periaqueductal gray shifts in humans. Science, 317(5841), 1079–1083. https://doi.org/https://doi.org/10.1126/science.1144298
- Motta, S. C., Carobrez, A. P., & Canteras, N. S. (2017). The periaqueductal gray and primal emotional processing critical to influence complex defensive responses, fear learning and reward seeking. Neuroscience and Biobehavioral Reviews, 76(Pt A), 39–47. https://doi.org/https://doi.org/10.1016/j.neubiorev.2016.10.012
- Najavits, L. M., Weiss, R. D., Shaw, S. R., & Muenz, L. R. (1998). Seeking safety”: Outcome of a new cognitive-behavioral psychotherapy for women with posttraumatic stress disorder and substance dependence. Journal of Traumatic Stress, 11(3), 437–456. https://doi.org/https://doi.org/10.1023/A:1024496427434
- Nashold, B. S., Jr., Wilson, W. P., & Slaughter, D. G. (1969). Stereotaxic midbrain lesions for central dysesthesia and phantom pain. Preliminary report. Journal of Neurosurgery, 30(2), 116–126. https://doi.org/https://doi.org/10.3171/jns.1969.30.2.0116
- Nashold, B. S., Jr., Wilson, W. P., & Slaughter, D. G. (1974). The midbrain and pain. In J. J. Bonica (Ed.), Advances in neurology, Vol 4: International symposium on pain (pp. 191–196). Raven Press.
- Norton, P. J., Hayes-Skelton, S. A., & Klenck, S. C. (2011). What happens in session does not stay in session: Changes within exposures predict subsequent improvement and dropout. Journal of Anxiety Disorders, 25(5), 654–660. https://doi.org/https://doi.org/10.1016/j.janxdis.2011.02.006
- Otto, M. W., McHugh, R. K., & Kantak, K. M. (2010). Combined pharmacotherapy and cognitive‐behavioral therapy for anxiety disorders: Medication effects, glucocorticoids, and attenuated treatment outcomes. Clinical Psychology: Science and Practice, 17(2), 91–103.
- Pani, P. P., Maremmani, A. G. I., Trogu, E., Vigna-Taglianti, F., Mathis, F., Diecidue, R., Kirchmayer, U., Amato, L., Davoli, M., Ghibaudi, J., Camposeragna, A., Saponaro, A., Faggiano, F., & Maremmani, I. (2016). Psychic structure of opioid addiction: Impact of lifetime psychiatric problems on SCL-90-based psychopathologic dimensions in heroin-dependent patients. Addictive Disorders & Their Treatment, 15(1), 6–16. https://doi.org/https://doi.org/10.1097/ADT.0000000000000072
- Panlilio, L. V., Stull, S. W., Kowalczyk, W. J., Phillips, K. A., Schroeder, J. R., Bertz, J. W., Vahabzadeh, M., Lin, J.-L., Mezghanni, M., Nunes, E. V., Epstein, D. H., & Preston, K. L. (2019). Stress, craving and mood as predictors of early dropout from opioid agonist therapy. Drug and Alcohol Dependence, 202, 200–208. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2019.05.026
- Paul, E. D., Johnson, P. L., Shekhar, A., & Lowry, C. A. (2014). The Deakin/Graeff hypothesis: Focus on serotonergic inhibition of panic. Neuroscience and Biobehavioral Reviews, 46 Pt 3, 379–396. https://doi.org/https://doi.org/10.1016/j.neubiorev.2014.03.010
- Pedersen, S., & Sayette, M. (2020). Education and training in substance use disorders: A roadmap to move forward. Training and Education in Professional Psychology, 14(1), 4–7. https://doi.org/https://doi.org/10.1037/tep0000303
- Persson, A., Back, S. E., Killeen, T. K., Brady, K. T., Schwandt, M. L., Heilig, M., & Magnusson, Å. (2017). Concurrent treatment of PTSD and substance use disorders using prolonged exposure (COPE): A pilot study in alcohol-dependent women. Journal of Addiction Medicine, 11(2), 119–125. https://doi.org/https://doi.org/10.1097/ADM.0000000000000286
- Petrakis, I. L., Poling, J., Levinson, C., Nich, C., Carroll, K., Rounsaville, B., & Group, V. N. E. V. I. M. S, VA New England VISN I MIRECC Study Group. (2005). Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders. Biological Psychiatry, 57(10), 1128–1137. https://doi.org/https://doi.org/10.1016/j.biopsych.2005.02.016
- Popik, P., Kamysz, E., Kreczko, J., & Wróbel, M. (2010). Human opiorphin: The lack of physiological dependence, tolerance to antinociceptive effects and abuse liability in laboratory mice. Behavioural Brain Research, 213(1), 88–93. https://doi.org/https://doi.org/10.1016/j.bbr.2010.04.045
- Preter, M., Lee, S. H., Petkova, E., Vannucci, M., Kim, S., & Klein, D. F. (2011). Controlled cross-over study in normal subjects of naloxone-preceding-lactate infusions; respiratory and subjective responses: Relationship to endogenous opioid system, suffocation false alarm theory and childhood parental loss. Psychological Medicine, 41(2), 385–393. https://doi.org/https://doi.org/10.1017/S0033291710000838
- Preter, M., & Klein, D. F. (2014). Lifelong opioidergic vulnerability through early life separation: A recent extension of the false suffocation alarm theory of panic disorder. Neuroscience and Biobehavioral Reviews, 46 Pt 3, 345–351. https://doi.org/https://doi.org/10.1016/j.neubiorev.2014.03.025
- Priester, M. A., Browne, T., Iachini, A., Clone, S., DeHart, D., & Seay, K. D. (2016). Treatment access barriers and disparities among individuals with co-occurring mental health and substance use disorders: An integrative literature review. Journal of Substance Abuse Treatment, 61, 47–59. https://doi.org/https://doi.org/10.1016/j.jsat.2015.09.006
- Reiman, E. M., Raichle, M. E., Robins, E., Mintun, M. A., Fusselman, M. J., Fox, P. T., Price, J. L., & Hackman, K. A. (1989). Neuroanatomical correlates of a lactate-induced anxiety attack. Archives of General Psychiatry, 46(6), 493–500. https://doi.org/https://doi.org/10.1001/archpsyc.1989.01810060013003
- Rickels, K., Schweizer, E., Weiss, S., & Zavodnick, S. (1993). Maintenance drug treatment for panic disorder. II. Short- and long-term outcome after drug taper. Archives of General Psychiatry, 50(1), 61–68. https://doi.org/https://doi.org/10.1001/archpsyc.1993.01820130067010
- Robinson, J. A., Sareen, J., Cox, B. J., & Bolton, J. M. (2009). Correlates of self-medication for anxiety disorders: Results from the National Epidemiolgic Survey on Alcohol and Related Conditions. The Journal of Nervous and Mental Disease, 197(12), 873–878. https://doi.org/https://doi.org/10.1097/NMD.0b013e3181c299c2
- Roncon, C. M., Biesdorf, C., Santana, R. G., Zangrossi, H., Graeff, F. G., & Audi, E. A. (2012). The panicolytic-like effect of fluoxetine in the elevated T-maze is mediated by serotonin-induced activation of endogenous opioids in the dorsal periaqueductal grey. Journal of Psychopharmacology, 26(4), 525–531. https://doi.org/https://doi.org/10.1177/0269881111434619
- Roncon, C. M., Yamashita, P. S., de, M., Frias, A. T., Audi, E. A., Graeff, F. G., Coimbra, N. C., & Zangrossi, H. (2017). μ-Opioid and 5-HT1A receptors in the dorsomedial hypothalamus interact for the regulation of panic-related defensive responses. Journal of Psychopharmacology, 31(6), 715–721. https://doi.org/https://doi.org/10.1177/0269881117693747
- Rosen, D., Smith, M. L., & Reynolds, C. F. III, (2008). The prevalence of mental and physical health disorders among older methadone patients. The American Journal of Geriatric Psychiatry, 16(6), 488–497. https://doi.org/https://doi.org/10.1097/JGP.0b013e31816ff35a
- Rosenblatt, R. A., Andrilla, C. H. A., Catlin, M., & Larson, E. H. (2015). Geographic and Specialty Distribution of US Physicians Trained to Treat Opioid Use Disorder. Annals of Family Medicine, 13(1), 23–26. https://doi.org/https://doi.org/10.1370/afm.1735
- Rosenblum, A., Cleland, C. M., Fong, C., Kayman, D. J., Tempalski, B., & Parrino, M. (2011). Distance traveled and cross-state commuting to opioid treatment programs in the United States. Journal of Environmental and Public Health, 2011, 1–10. https://doi.org/https://doi.org/10.1155/2011/948789
- Sareen, J., Chartier, M., Paulus, M. P., & Stein, M. B. (2006). Illicit drug use and anxiety disorders: Findings from two community surveys. Psychiatry Research, 142(1), 11–17. https://doi.org/https://doi.org/10.1016/j.psychres.2006.01.009
- Saxon, A. J., Oreskovich, M. R., & Brkanac, Z. (2005). Genetic determinants of addiction to opioids and cocaine. Harvard Review of Psychiatry, 13(4), 218–232. https://doi.org/https://doi.org/10.1080/10673220500243364
- Sestile, C. C., Maraschin, J. C., Gama, V. S., Zangrossi, H., Graeff, F. G., & Audi, E. A. (2017). Panicolytic-like action of bradykinin in the dorsal periaqueductal gray through μ-opioid and B2-kinin receptors. Neuropharmacology, 123, 80–87. https://doi.org/https://doi.org/10.1016/j.neuropharm.2017.05.025
- Sigmon, S. C. (2014). Access to treatment for opioid dependence in rural America: Challenges and future directions. JAMA Psychiatry, 71(4), 359–360. https://doi.org/https://doi.org/10.1001/jamapsychiatry.2013.4450
- Sinha, S. S., Goetz, R. R., & Klein, D. F. (2007). Physiological and behavioral effects of naloxone and lactate in normal volunteers with relevance to the pathophysiology of panic disorder. Psychiatry Research, 149(1–3), 309–314. https://doi.org/https://doi.org/10.1016/j.psychres.2004.11.011
- Sordo, L., Barrio, G., Bravo, M. J., Indave, B. I., Degenhardt, L., Wiessing, L., Ferri, M., & Pastor-Barriuso, R. (2017). Mortality risk during and after opioid substitution treatment: Systematic review and meta-analysis of cohort studies. British Medical Journal, 357, 1–14.
- Substance Abuse and Mental Health Services Administration. (2019). Key substance use and mental health indicators in the United States: Results from the 2018 National Survey on Drug Use and Health. Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. https://www.samhsa.gov/data/
- Sullivan, M. D., Edlund, M. J., Steffick, D., & Unützer, J. (2005). Regular use of prescribed opioids: Association with common psychiatric disorders. Pain, 119(1–3), 95–103. https://doi.org/https://doi.org/10.1016/j.pain.2005.09.020
- Sullivan, M. D., Edlund, M. J., Zhang, L., Unützer, J., & Wells, K. B. (2006). Association between mental health disorders, problem drug use, and regular prescription opioid use. Archives of Internal Medicine, 166(19), 2087–2093. https://doi.org/https://doi.org/10.1001/archinte.166.19.2087
- Turner, L., Kruszewski, S. P., & Alexander, G. C. (2015). Trends in the use of buprenorphine by office-based physicians in the United States, 2003–2013. The American Journal on Addictions, 24(1), 24–29. https://doi.org/https://doi.org/10.1111/ajad.12174
- Volkow, N. D., Frieden, T. R., Hyde, P. S., & Cha, S. S. (2014). Medication-assisted therapies—Tackling the opioid-overdose epidemic. New England Journal of Medicine, 370(22), 2063–2066. https://doi.org/https://doi.org/10.1056/NEJMp1402780
- Weiss, R. D., Potter, J. S., Fiellin, D. A., Byrne, M., Connery, H. S., Dickinson, W., Gardin, J., Griffin, M. L., Gourevitch, M. N., & Haller, D. L. (2011). Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: A 2-phase randomized controlled trial. Archives of General Psychiatry, 68(12), 1238–1246. https://doi.org/https://doi.org/10.1001/archgenpsychiatry.2011.121
- Wilsey, B. L., Fishman, S. M., Tsodikov, A., Ogden, C., Symreng, I., & Ernst, A. (2008). Psychological comorbidities predicting prescription opioid abuse among patients in chronic pain presenting to the emergency department. Pain Medicine, 9(8), 1107–1117. https://doi.org/https://doi.org/10.1111/j.1526-4637.2007.00401.x
- Yi, H., Iida, T., Liu, S., Ikegami, D., Liu, Q., Iida, A., Lubarsky, D. A., & Hao, S. (2017). IL-4 mediated by HSV vector suppresses morphine withdrawal response and decreases TNFα, NR2B, and pC/EBPβ in the periaqueductal gray in rats. Gene Therapy, 24(4), 224–233. https://doi.org/https://doi.org/10.1038/gt.2017.11